856 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Clinical Trials of SGLT2 ... ASCVD; signal for SGLT2i ... risk; signal for SGLT2i ... #inhibitors #EBM ... #trial #visualabstract
SGLT2 Inhibitors and Cardiovascular Pathophysiology

#SGLT2i #Inhibitors #Cardiovascular #Pathophysiology
SGLT2 Inhibitors ... Pathophysiology #SGLT2i
Pathophysiology Euglycemic DKA - Mechanism of SGLT-2 Inhibitors #Pathophys #Endocrine #Euglycemic #DKA #SGLT2 #Mechanism
- Mechanism of SGLT ... Euglycemic #DKA #SGLT2
How SGLT2 inhibitors block glucose reabsorption in proximal tubule and improve systemic glucose homeostasis:
https://www.ajkd.org/article/S0272-6386(18)30633-4/fulltext

#Pathophysiology #Mechanism #Nephrology
How SGLT2 inhibitors ... Mechanism #Nephrology #SLGT2
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
comparison between SGLT ... cardiovascular #renal #SGLT2i
SGLT2 Inhibitors and Euglycemic DKA

Risk factors for euglycemic DKA in those on an SGLT2i include:
 •
SGLT2 Inhibitors ... in those on an SGLT2i ... is closed • SGLT2 ... Kat_Watson #SGLT2
Summary of Major Trials of Steroids in Sepsis

- Vivek Moitra, MD
@vmoitra

#Steroids #Sepsis #Corticosteroids #EBM #Evidence #Trials
Corticosteroids #EBM ... Evidence #Trials #VisualAbstract
Diabetic Nephropathy - Timeline of Important Trials

Dr. Lovy Gaur https://twitter.com/drlovygaur

#Diabetic #Nephropathy #EBM #VisualAbstract #Trials #Nephrology #Timeline
#Nephropathy #EBM ... #VisualAbstract
PCI in Acute MI with Cardiogenic Shock. #EBM #Cardiology #CULPRITSHOCK #PCI #VisualAbstract #NEJM
#EBM #Cardiology ... CULPRITSHOCK #PCI #VisualAbstract
Ruling out Pulmonary Embolism - ADJUST-PE, PE in Pregnancy, and the PERC rule

- DenverEM
@DenverEMed

#Pulmonary #Embolism #VisualAbstract
Pulmonary #Embolism #VisualAbstract ... #ADJUSTPE #EBM